Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Fluoropharma Inc. (FPMI) Starts Presentation at the 2012 Aegis Healthcare Conference

Fluoropharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FPMI’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents … Continue reading

Posted in Aegis Conference | Leave a comment

Organovo Holdings Inc. (ONVO) Starts Presentation at the 2012 Aegis Healthcare Conference

Organovo Holdings is a 3D biology company focused on delivering bioprinting technology and creating tissue on demand for research and medical applications. The company’s NovoGen 3D bioprinting technology is a platform that works across all tissue and cell types. ONVO … Continue reading

Posted in Aegis Conference | Leave a comment

Bio Specifics Technologies Corp. (BSTC) Starts Presentation at the 2012 Aegis Healthcare Conference

Bio Specifics Technologies is the developer of an injectable collagenase, XIAFLEX®, for 12 clinical indications. Currently, XIAFLEX is marketed in the U.S. for the treatment of adult Dupuytren’s contracture patients with a palpable cord by Auxilium Pharmaceuticals, and is also … Continue reading

Posted in Aegis Conference | Leave a comment

VentriPoint Diagnostics Ltd. (VPTDF) Starts Presentation at the 2012 Aegis Healthcare Conference

VentriPoint Diagnostics is a medical device company engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease primarily in Canada and Europe. The company’s VentriPoint Diagnostic System is used to generate critical shape and volume … Continue reading

Posted in Aegis Conference | Leave a comment

Lpath Inc. (LPTN) Starts Presentation at the 2012 Aegis Healthcare Conference

Lpath is a biotech company focused on the discovery and development of lipidomic-based therapeutic antibodies for treating human diseases primarily in the United States. LPTN’s lead product candidate, iSONEPTM, is currently in two clinical trials to evaluate the safety and … Continue reading

Posted in Aegis Conference | Leave a comment

Tonix Pharmaceuticals Holding Corp. (TNXP) Starts Presentation at the 2012 Aegis Healthcare Conference

Tonix Pharmaceuticals Holding is a development-stage specialty pharmaceutical company focused on the development of pharmaceutical products for central nervous system conditions. The company’s lead product candidates include TNX-102, for the management of fibromyalgia syndrome; and TNX-105, for the treatment of … Continue reading

Posted in Aegis Conference | Leave a comment

Rosetta Genomics Ltd. (ROSG) Starts Presentation at the 2012 Aegis Healthcare Conference

Rosetta Genomics is a molecular diagnostics company that develops and commercializes a range of microRNA-based molecular diagnostic tests. ROSG’s product portfolio includes: miRview®lung,  miRview®squamos, miRview®meso and miRview®kidney. The company also has a collaboration agreement with the University of California, Davis, … Continue reading

Posted in Aegis Conference | Leave a comment

Galectin Therapeutics Inc. (GALT) Starts Presentation at the 2012 Aegis Healthcare Conference

Galectin Therapeutics is a development-stage company engaged in developing carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer. GALT also has a colorectal cancer program moving toward commercialization. The company’s lead product candidate is a candidate for cancer … Continue reading

Posted in Aegis Conference | Leave a comment

Synergy Pharmaceuticals, Inc. (SGYP) Starts Presentation at the 2012 Aegis Healthcare Conference

Synergy Pharmaceuticals is developing new drugs to treat gastrointestinal disorders and diseases. Plecanatide, the company’s lead proprietary drug candidate, functions by activating the guanylate cyclase C receptor on epithelial cells of the GI tract. Synergy completed a Phase I study … Continue reading

Posted in Aegis Conference | Leave a comment

IntelGenx Technologies Corp. (IGXT) Starts Presentation at the 2012 Aegis Healthcare Conference

IntelGenx Technologies is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IGXT has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the … Continue reading

Posted in Aegis Conference | Leave a comment